Increasing prevalence of hypertension is expected to propel growth of the renal denervation devices market

 

Renal Denervation Devices
Renal Denervation Devices 

In the treatment of uncontrolled or persistent hypertension, if hypertensive medicine is unsuccessful, renal denervation devices play a significant role in contemporary healthcare. A catheter used in the operation emits radiofrequency energy across several electrodes.

A significant driver of the renal denervation industry is the rise in clinical trials for the treatment of diseases including hypertension and blood pressure. This increase in trials is anticipated to increase the demand for renal denervation and present new prospects for Renal Denervation Devices market participants. It is anticipated that new clinical trials will provide a scope of development in advanced economies like Europe and the United States. For instance, the ongoing RADIANCE-HTN trial in Connecticut is being pioneered by Stanford Health. Several centres in Europe and the United States are connected to the multicenter, worldwide trial.

The constraints of a renal denervation system based on radiofrequency can be overcome by using ultrasound technology. Without directly touching the tissues, the high-frequency sound waves of the ultrasound energy aid in the ablation of the nerves. This lessens injury to the renal arteries.

Comments

Popular posts from this blog

The Role of the Foodservice Industry in Driving the French Fries Market

Market Share and Revenue Analysis of the Microdermabrasion Devices Market

The Growing Demand for Healthcare Staffing Market: Trends and Opportunities